Literature DB >> 26386835

Identification and functional analysis of a novel CaSR mutation in a family with familial hypocalciuric hypercalcemia.

Eun Sook Kim1, Su Yeon Kim1, Ji Young Lee1, Je Ho Han1, Tae Seo Sohn2, Hyun Shik Son3, Sung-Dae Moon4.   

Abstract

The calcium-sensing receptor (CaSR) is a G-protein-coupled receptor that plays an essential role in maintaining calcium homeostasis. In the present study, we analyzed the CaSR gene in a Korean family with familial hypocalciuric hypercalcemia (FHH). Genetic studies were performed by direct sequence analysis of the CaSR gene in genomic DNA obtained from peripheral leukocytes. A novel heterozygous G to T substitution at nucleotide position 1711 in exon 6, resulting in the G571W mutation, was identified in the CaSR gene in a 26-year-old female with asymptomatic hypercalcemia, a low calcium/creatinine clearance ratio, and normal intact parathyroid hormone. To study CaSR expression, the mutation was introduced by site-directed mutagenesis into a wild-type (WT) CaSR-expressing pCR3.1 vector, and COS-7 cells were transfected with either the WT or mutant CaSR-containing vector. Transfected cells loaded with Fura-2/AM, a fluorescent indicator of Ca2+, were assessed for CaSR function by the change in intracellular calcium [as measured by the 340 nm/380 nm fluorescence intensity ratio (F340/F380)] made in response to challenge with extracellular Ca2+. Both WT and G571W cells had equivalent amounts of CaSR protein in the cell membrane. However, after challenge with extracellular Ca2+, cells transfected with G571W CaSR responded with a lower F340/F380 ratio than those transfected with WT CaSR and showed decreased sensitivity to extracellular Ca2+ concentrations. The G571W mutation had therefore impaired the CaSR function. In conclusion, we identified a novel loss-of-function mutation, G571W, in the CaSR gene in a Korean family with FHH.

Entities:  

Keywords:  Autosomal dominant; Calcium-sensing receptor; Familial hypocalciuric hypercalcemia

Mesh:

Substances:

Year:  2015        PMID: 26386835     DOI: 10.1007/s00774-015-0713-z

Source DB:  PubMed          Journal:  J Bone Miner Metab        ISSN: 0914-8779            Impact factor:   2.626


  18 in total

Review 1.  Disorders involving calcium, phosphorus, and magnesium.

Authors:  Sharon M Moe
Journal:  Prim Care       Date:  2008-06       Impact factor: 2.907

2.  Calcium-sensing receptor mutations in familial hypocalciuric hypercalcaemia with recurrent pancreatitis.

Authors:  S H Pearce; C Wooding; M Davies; S E Tollefsen; M P Whyte; R V Thakker
Journal:  Clin Endocrinol (Oxf)       Date:  1996-12       Impact factor: 3.478

3.  Two novel mutations of the calcium-sensing receptor gene affecting the same amino acid position lead to opposite phenotypes and reveal the importance of p.N802 on receptor activity.

Authors:  Anne-Sophie Lia-Baldini; Corinne Magdelaine; Angélique Nizou; Coraline Airault; Jean-Pierre Salles; Pierre Moulin; Brigitte Delemer; Mina Aitouares; Benoît Funalot; Franck Sturtz; Anne Lienhardt-Roussie
Journal:  Eur J Endocrinol       Date:  2013-01-17       Impact factor: 6.664

4.  Familial hypercalcemia and hypercalciuria caused by a novel mutation in the cytoplasmic tail of the calcium receptor.

Authors:  T Carling; E Szabo; M Bai; P Ridefelt; G Westin; P Gustavsson; S Trivedi; P Hellman; E M Brown; N Dahl; J Rastad
Journal:  J Clin Endocrinol Metab       Date:  2000-05       Impact factor: 5.958

Review 5.  The extracellular calcium-sensing receptor: its role in health and disease.

Authors:  E M Brown; M Pollak; S C Hebert
Journal:  Annu Rev Med       Date:  1998       Impact factor: 13.739

6.  Identification and functional characterization of a novel mutation in the calcium-sensing receptor gene in familial hypocalciuric hypercalcemia: modulation of clinical severity by vitamin D status.

Authors:  Katerina Zajickova; Jana Vrbikova; Lucie Canaff; Peter D Pawelek; David Goltzman; Geoffrey N Hendy
Journal:  J Clin Endocrinol Metab       Date:  2007-05-01       Impact factor: 5.958

7.  A novel Ca2+ influx pathway activated by mechanical stretch in human airway smooth muscle cells.

Authors:  Satoru Ito; Hiroaki Kume; Keiji Naruse; Masashi Kondo; Naoya Takeda; Susumu Iwata; Yoshinori Hasegawa; Masahiro Sokabe
Journal:  Am J Respir Cell Mol Biol       Date:  2007-11-01       Impact factor: 6.914

8.  Codon Arg15 mutations of the AP2S1 gene: common occurrence in familial hypocalciuric hypercalcemia cases negative for calcium-sensing receptor (CASR) mutations.

Authors:  Geoffrey N Hendy; Lucie Canaff; Ron S Newfield; Liana Tripto-Shkolnik; Betty Y L Wong; Bonnie S P Lee; David E C Cole
Journal:  J Clin Endocrinol Metab       Date:  2014-04-14       Impact factor: 5.958

9.  Familial hypocalciuric hypercalcemia revealed by chondrocalcinosis.

Authors:  Alessandro Volpe; Andrea Guerriero; Antonio Marchetta; Paola Caramaschi; Lino Furlani
Journal:  Joint Bone Spine       Date:  2009-12       Impact factor: 4.929

10.  Genetic testing in familial isolated hyperparathyroidism: unexpected results and their implications.

Authors:  J Warner; M Epstein; A Sweet; D Singh; J Burgess; S Stranks; P Hill; D Perry-Keene; D Learoyd; B Robinson; P Birdsey; E Mackenzie; B T Teh; J B Prins; J Cardinal
Journal:  J Med Genet       Date:  2004-03       Impact factor: 6.318

View more
  1 in total

1.  Prevention of Injury-Induced Osteoarthritis in Rodent Temporomandibular Joint by Targeting Chondrocyte CaSR.

Authors:  Mian Zhang; Hongxu Yang; Xianghong Wan; Lei Lu; Jing Zhang; Hongyun Zhang; Tao Ye; Qian Liu; Mianjiao Xie; Xiaodong Liu; Shibin Yu; Shaoxiong Guo; Wenhan Chang; Meiqing Wang
Journal:  J Bone Miner Res       Date:  2019-01-07       Impact factor: 6.390

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.